Hemostasis in Pre-Eclamptic Women and Their Offspring: Current Knowledge and Hemostasis Assessment with Viscoelastic

Christos-Georgios Kontovazainitis1, Dimitra Gialamprinou1, Theodoros Theodoridis2

  • 12nd Neonatal Department and Neonatal Intensive Care Unit (NICU), "Papageorgiou" University Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.

PubMed

Insights

Pre-eclampsia disrupts normal blood clotting, causing hypercoagulability. Viscoelastic tests like TEG/ROTEM show this excessive clotting, aiding in monitoring and predicting pre-eclampsia severity.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatology

Background:

  • Pre-eclampsia (PE) is a serious pregnancy complication affecting maternal and neonatal health.
  • PE disrupts the normal hypercoagulable state of pregnancy, leading to abnormal blood clotting and fibrinolysis.
  • Conventional coagulation tests (CCTs) are insufficient for monitoring hemostatic changes in PE.

Purpose of the Study:

  • To review hemostasis in pre-eclampsia compared to normal pregnancy.
  • To explore maternal PE's impact on neonatal hemostasis.
  • To discuss the utility of viscoelastic tests (TEG/ROTEM) for assessing and monitoring PE-associated hemostatic alterations.

Main Methods:

  • This is a narrative review summarizing current knowledge.
  • Focuses on comparing hemostasis in PE versus healthy gestation.
  • Emphasizes the role of thromboelastography (TEG) and thromboelastometry (ROTEM) in PE.

Main Results:

  • TEG/ROTEM reveal excessive hypercoagulability in PE, correlating with disease severity.
  • PE is characterized by the formation of higher-stability fibrin clots compared to normal pregnancy.
  • TEG/ROTEM parameters show potential as monitoring and predictive markers for PE.

Conclusions:

  • Viscoelastic testing (TEG/ROTEM) offers a valuable tool for assessing PE-related hemostatic changes.
  • TEG/ROTEM can reflect PE severity and may aid in disease monitoring and prediction.
  • Further consideration of TEG/ROTEM in PE management is warranted due to CCT limitations.

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...